Your browser does not support inline frames or is currently configured not to display inline frames. Content can be viewed at actual source page: inc/head.html
PDBsum entry 5jeb
Go to PDB code:
Transferase/transferase inhibitor
PDB id
5jeb
Loading ...
Contents
Protein chain
299 a.a.
Ligands
SO4
×2
6JS
PDB id:
5jeb
Links
PDBe
RCSB
MMDB
JenaLib
Proteopedia
CATH
SCOP
PDBSWS
PDBePISA
ProSAT
Name:
Transferase/transferase inhibitor
Title:
Crystal structure of egfr tyrosine kinase domain with novel inhibitor of active state of her2
Structure:
Epidermal growth factor receptor. Chain: a. Fragment: unp residues 696-1022. Synonym: proto-oncogenE C-erbb-1,receptor tyrosine-protein kinase erbb-1. Engineered: yes. Mutation: yes
Source:
Homo sapiens. Human. Organism_taxid: 9606. Gene: egfr, erbb, erbb1, her1. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108.
Resolution:
3.30Å
R-factor:
0.244
R-free:
0.270
Authors:
J.H.Park,M.A.Lemmon
Key ref:
C.J.Novotny et al. (2016). Overcoming resistance to HER2 inhibitors through state-specific kinase binding.
Nat Chem Biol
,
12
, 923-930.
PubMed id:
27595329
DOI:
10.1038/nchembio.2171
Date:
18-Apr-16
Release date:
07-Sep-16
PROCHECK
Headers
References
Protein chain
?
P00533
(EGFR_HUMAN) - Epidermal growth factor receptor from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1210 a.a.
299 a.a.
*
Key:
PfamA domain
Secondary structure
CATH domain
*
PDB and UniProt seqs differ at 1 residue position (black cross)
Enzyme reactions
Enzyme class:
E.C.2.7.10.1
- receptor protein-tyrosine kinase.
[IntEnz]
[ExPASy]
[KEGG]
[BRENDA]
Reaction:
L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H
+
L-tyrosyl-[protein]
+
ATP
=
O-phospho-L-tyrosyl-[protein]
+
ADP
+
H(+)
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
Added reference
DOI no:
10.1038/nchembio.2171
Nat Chem Biol
12
:923-930 (2016)
PubMed id:
27595329
Overcoming resistance to HER2 inhibitors through state-specific kinase binding.
C.J.Novotny,
S.Pollari,
J.H.Park,
M.A.Lemmon,
W.Shen,
K.M.Shokat.
ABSTRACT
No abstract given.
'); } }